Home > Boards > Free Zone > All Trading - Technical > General Stock Ideas

Ombow, Just curious if you are still

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
gfp927z Member Profile
 
Followed By 61
Posts 23,900
Boards Moderated 74
Alias Born 03/22/05
160x600 placeholder
Amazon Faces Questions Over Removal of Book by Conservative Author -- Update
A group of Republican senators is asking Amazon.com Inc. to explain why it recently removed a book about transgender issues that had been on sale on the platform for about three years.
WeWork's Adam Neumann to Get Extra $50 Million Payout in SoftBank Settlement
Top Company News of the Day
Boeing-FAA Ties Still Flawed After 737 MAX Reforms
Republican Senators Send Letter to Jeff Bezos Asking Why Amazon Pulled Book by Conservative Author
Facebook, Google Face 'Strong Pipeline' of Privacy Rulings in Europe
Federal Reserve Financial-Services Systems Disrupted for Hours -- 6th Update
Graphics-Chip Maker Nvidia Lifts Revenue Amid Videogame Boom -- 3rd Update
Graphics-Chip Maker Nvidia Lifts Revenue Amid Videogame Boom -- 2nd Update
Federal Reserve Financial-Services Systems Disrupted for Hours -- 5th Update
Top Stories of the Day
Graphics-Chip Maker Nvidia Lifts Revenue Amid Videogame Boom -- Update
Graphic-Chips Maker Nvidia Lifts Revenue Amid Videogame Boom
Federal Reserve Financial-Services Systems Disrupted for Hours -- 4th Update
Dow Industrials Close at a Record--Update
Israeli Study Finds Pfizer Shot Equally Effective for Young and Old
Verizon Tops List of 5G Spectrum Bidders -- 2nd Update
Sycamore's Belk to Exit Bankruptcy Within One Day
Verizon Tops List of 5G Spectrum Bidders -- Update
Verizon Tops List of 5G Spectrum Bidders
Correction to Stocks End Wild Session Article on Feb. 23
Booking Holdings, Hit Hard by the Pandemic, Swings to 4Q Loss
Federal Reserve Financial-Services Systems Disrupted for Hours -- 3rd Update
gfp927z   Tuesday, 02/23/21 08:31:53 PM
Re: ombowstring post# 18714
Post # of 18748 
Ombow, Just curious if you are still in CYDY? In addition to the company sitting on the trial results, looking at the recent press release the emphasis is clearly being shifted away from Covid and onto their other programs, HIV, cancer, etc. That shift is really obvious, and they are lowering expectations for Covid. I've seen this type spin before in bio press releases.

The idea that a company can just sit on clinical data almost indefinitely is something I've never seen before with a small bio. Large companies can bury disappointing trial results, but a small company can't legally do that since they often only have one lead drug and the company's future is riding on it. So key clinical data is a material event that must be disclosed to shareholders. At least that's the way it always was when I was following bio companies, which admittedly was a few years back.

But this weasel CEO seems to think he can just sit on key data, put it off week after week. The company's silence has been a huge red flag. They delayed the mild/mod trial data release also, but not this long.
With good clear positive data, the press release announcement usually comes quickly. I wouldn't trust that CEO even a little, zip.













Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences